{"id":"NCT03345849","sponsor":"AbbVie","briefTitle":"A Study of the Efficacy and Safety of Upadacitinib in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional and/or Biologic Therapies","officialTitle":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional and/or Biologic Therapies","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-12-07","primaryCompletion":"2021-10-15","completion":"2022-01-13","firstPosted":"2017-11-17","resultsPosted":"2022-11-23","lastUpdate":"2022-11-23"},"enrollment":526,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Crohn's Disease"],"interventions":[{"type":"DRUG","name":"Upadacitinib","otherNames":["ABT-494","RINVOQ"]},{"type":"DRUG","name":"Placebo for Upadacitinib","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Upadacitinib","type":"EXPERIMENTAL"}],"summary":"The objective of this study is to evaluate the efficacy and safety of upadacitinib compared to placebo as induction therapy in adults with moderately and severely active Crohn's disease (CD).","primaryOutcome":{"measure":"Percentage of Participants With Clinical Remission Per Crohn's Disease Activity Index (CDAI) at Week 12","timeFrame":"Week 12","effectByArm":[{"arm":"Placebo","deltaMin":29.1,"sd":null},{"arm":"Upadacitinib 45 mg QD","deltaMin":49.5,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":6},"locations":{"siteCount":432,"countries":["United States","Argentina","Australia","Austria","Belgium","Bosnia and Herzegovina","Brazil","Bulgaria","Canada","Chile","China","Colombia","Croatia","Czechia","Denmark","Egypt","Estonia","France","Germany","Greece","Hong Kong","Hungary","Ireland","Israel","Italy","Japan","Latvia","Lithuania","Malaysia","Mexico","Netherlands","Poland","Portugal","Puerto Rico","Romania","Russia","Serbia","Singapore","Slovakia","Slovenia","South Africa","South Korea","Spain","Sweden","Switzerland","Taiwan","Turkey (TÃ¼rkiye)","Ukraine","United Kingdom"]},"refs":{"pmids":["39231444","38835235","38492904","38492903","37224198"],"seeAlso":["https://www.rxabbvie.com"]},"adverseEventsSummary":{"seriousAny":{"events":12,"n":176},"commonTop":["ANAEMIA","ACNE","NASOPHARYNGITIS","CROHN'S DISEASE","ARTHRALGIA"]}}